Ufp Technologies (UFPT) risk factors, FY2024 10-K

Risks Related to our Business

1. 01Our business, operating results, and cash flows have historically been affected and may continue to be adversely affected by inflation
2. 02The ongoing conflict between Russia and Ukraine, other similar conflicts and civil unrest in Haiti, which is in proximity to our manufacturing facilities in the Dominican Republic could have a material adverse effect on our business and results of operations
3. 03Our business could be harmed if our products contain undetected errors or defects or do not meet applicable specifications
4. 04New technologies could result in the development of new products by our competitors and a decrease in demand for our products, which could materially adversely affect our business, financial condition and results of operations
5. 05If we fail to comply with specific provisions of our customer contracts or Food and Drug Administration (FDA) regulations, our business could be materially adversely affected
6. 06Increased focus and evolving views of lawmakers on climate change and other ESG issues could have a long-term impact on our business and result of operations
7. 07Global climate change and related regulations and changes in customer demand could negatively affect our operations and our business
8. 08We may pursue acquisitions or other strategic relationships that involve inherent risks, any of which may cause us to not realize anticipated benefits
9. 09Failure to retain key personnel could impair our ability to execute our business strategy
10. 10We operate in highly competitive industries, and we may be unable to compete successfully, which could materially adversely affect our business, financial condition and results of operations
11. 11Security breaches, including cybersecurity incidents and other disruptions could compromise our information, expose us to liability and harm our reputation and business
12. 12Disruptions in the supply of components and raw materials we use in manufacturing our products could cause production delays or reductions in the number of products we manufacture, which could materially adversely affect our business, financial condition, and results of operations
13. 13We may be unable to protect our proprietary technology from infringement
14. 14Our products could infringe the intellectual property rights of others, which may lead to litigation that could itself be costly, result in the payment of substantial damages or royalties, and prevent us from using technology that is essential to our products
15. 15Redesign or rename, in the case of trademark claims, our products to avoid infringing the intellectual property rights of third parties, which may be costly and time-consuming, even if possible
16. 16Reductions in the availability of energy supplies or an increase in energy costs may increase our operating costs
17. 17Consolidation in the healthcare industry could result in greater competition and reduce our net sales and harm our business
18. 18Expansion of our operations into markets outside of the U.S. subjects us to political, economic, legal, operational, and other risks that could have a material adverse effect on our business, results of operations, financial condition, cash flows and reputation
19. 19Issues relating to the failure to comply with applicable non-U.S. laws, requirements or restrictions may also impact our domestic business and increase scrutiny of our domestic practices
20. 20These risks could have a material adverse effect on our business, results of operations, financial condition, and cash flows, and could materially harm our reputation

Risks Related to our Share Ownership and our Capital Structure

1. 21Restrictions in our credit facilities may limit our business and financial activities, including our ability to obtain additional capital in the future
2. 22Provisions of our corporate charter documents and Delaware law, may dissuade potential acquirers, prevent the replacement or removal of our current management, and may thereby affect the price of our common stock

Financial Risks

1. 23Our operating results may fluctuate, which may make it difficult to forecast our future performance and may result in volatility in our stock price
2. 24Our international sales and operations are subject to a variety of market and financial risks and costs that could affect our profitability and operating results
3. 25These risks are also present in connection with our entry into new geographic markets
4. 26We may never realize the full value of our intangible assets, which represent a significant portion of our total assets

General Risks

1. 27We are subject to a variety of federal, state and local laws and regulations, including health and safety laws and regulations, and the cost of complying, or our failure to comply, with such requirements could materially adversely affect our business, financial condition and results of operations
2. 28Our operations could be disrupted by natural or human causes beyond our control